151751-Najiba-Chargi

137 Surgery: skeletal muscle mass, systemic inflammation and flap reconstruction 29. Moyes LH, Leitch EF, McKee RF, Anderson JH, Horgan PG, McMillan DC. Preoperative systemic inflammation predicts postopera- tive infectious complications in patients un- dergoing curative resection for colorectal cancer. Br J Cancer . 2009;100(8):1236-1239. doi:10.1038/sj.bjc.6604997 30. McCluney SJ, Giakoustidis A, Segler A, et al. Neutrophil: Lymphocyte ratio as a method of predicting complications following he- patic resection for colorectal liver metas- tasis. J Surg Oncol . 2018;117(5):1058-1065. doi:10.1002/jso.24996 31. Dindo D, Demartines N, Clavien PA. Clas - sification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg . 2004;240(2):205-213. doi:10.1097/01. sla.0000133083.54934.ae 32. Azab B, Camacho-RiveraM, Taioli E. Average values and racial differences of neutrophil lymphocyte ratio among a nationally repre- sentative sample of United States subjects. PLoS One . 2014;9(11). doi:10.1371/journal. pone.0112361 33. Yoo W, Mayberry R, Bae S, Singh K, Peter He Q, Lillard JW. A Study of Effects of Mul - tiCollinearity in the Multivariable Analysis. Int J Appl Sci Technol . 2014;4(5):9-19. http:// www.ncbi.nlm.nih.gov/pubmed/25664257. Accessed January 1, 2021. 34. Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: A sys- tematic, quantitative review. Cancer . 2001;91(12):2214-2221. doi:10.1002/1097- 0142(20010615)91:12<2214::AID - CN - CR1251 >3.0.CO ;2-P 35. Van De Pol SMG, Doornaert PAH, De Bree R, Leemans CR, Slotman BJ, Langendijk JA. The significance of anemia in squamous cell head and neck cancer treated with surgery and postoperative radiotherapy. Oral Oncol . 2006;42(2):131-138. doi:10.1016/j.oraloncol - ogy.2005.06.021 36. Feliciano EMC, Kroenke CH, Meyerhardt JA, et al. Association of Systemic Inflam - mation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. JAMA Oncol . 2017;3(12):e172319. doi:10.1001/jamaon - col.2017.2319 37. Zhang S, Tan S, Jiang Y, et al. Sarcopenia as a predictor of poor surgical and oncologic outcomes after abdominal surgery for di - gestive tract cancer: A prospective cohort study. Clin Nutr . 2019;38(6):2881-2888. doi:10.1016/j.clnu.2018.12.025 38. Ubachs J, Ziemons J, Minis-Rutten IJG, et al. Sarcopenia and ovarian cancer survival: a systematic review and meta-analysis. J Ca- chexia Sarcopenia Muscle . 2019;10(6):1165- 1174. doi:10.1002/jcsm.12468 39. Nakamura H, Makiguchi T, Yamaguchi T, Fujii T, Shirabe K, Yokoo S. Impact of skele - tal musclemass on complications following expander breast reconstruction. J Plast Re- constr Aesthetic Surg . 2020;73(7):1285-1291. doi:10.1016/j.bjps.2020.02.006 40. Shi B, Liu S, Chen J, et al. Sarcopenia is As - sociated with Perioperative Outcomes in Gastric Cancer Patients Undergoing Gas - trectomy. Ann Nutr Metab . 2020;75(4):213- 222. doi:10.1159/000504283 41. Kawaguchi Y, Hanaoka J, Ohshio Y, et al. Sarcopenia predicts poor postoper - ative outcome in elderly patients with lung cancer. Gen Thorac Cardiovasc Surg . 2019;67(11):949-954. doi:10.1007/s11748- 019-01125-3 42. Chan MY, Chok KSH. Sarcopenia in pancre - atic cancer - effects on surgical outcomes and chemotherapy. World J Gastrointest Oncol . 2019;11(7):527-537. doi:10.4251/ wjgo.v11.i7.527 43. Karin M. Nuclear factor-κB in cancer de - velopment and progression. Nature . 2006;441(7092):431-436. doi:10.1038/ nature04870 7